Literature DB >> 27312922

End-Stage Renal Disease in an Infant With Hajdu-Cheney Syndrome.

Nina Battelino1, Karin Writzl2, Nevenka Bratanič3, Melita D Irving4,5, Gregor Novljan1,6.   

Abstract

Hajdu-Cheney syndrome (HJCYS) is a rare, autosomal dominant, skeletal disorder caused by mutations in the NOTCH2 signaling pathway for which genetic testing has recently become available. Renal abnormalities are associated in at least 10% of cases. We present an 8-year-old Caucasian boy, born with multiple dysmorphic features consistent with HJCYS. Imaging of the urinary tract revealed bilateral cystic dysplastic kidneys with associated vesicoureteral reflux. Renal function has been impaired since birth and deteriorated progressively to end-stage renal disease (ESRD) by the age of two and a half years, when peritoneal dialysis was initiated and only recently renal transplantation was performed. Additional congenital abnormalities and multisystem involvement in HJCYS further complicated management, and he developed refractory anemia. Molecular diagnosis was confirmed by identification of a truncating mutation in exon 34 of NOTCH2. Although, renal abnormalities are considered an integral part of the HJCYS, published reports on ESRD are scarce. In those few published cases, where ESRD was recognized, renal failure developed either in late adolescence or adulthood. This is the first report of early ESRD occurring in a child. Patients with HJCYS may need chronic renal replacement therapy even in early childhood. The management of these children can be challenging given the multisystemic manifestations of HJCYS.
© 2016 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.

Entities:  

Keywords:  Anemia; End-stage renal failure; Hajdu-Cheney syndrome; NOTCH2; Serpentine fibula polycystic kidney syndrome

Mesh:

Substances:

Year:  2016        PMID: 27312922     DOI: 10.1111/1744-9987.12444

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  5 in total

Review 1.  Notch Signaling in Vascular Smooth Muscle Cells.

Authors:  J T Baeten; B Lilly
Journal:  Adv Pharmacol       Date:  2016-08-26

Review 2.  Notch Signaling in Kidney Development, Maintenance, and Disease.

Authors:  Malini Mukherjee; Eric Fogarty; Madhusudhana Janga; Kameswaran Surendran
Journal:  Biomolecules       Date:  2019-11-04

3.  Hajdu Cheney Syndrome due to NOTCH2 defect - First case report from Pakistan and review of literature.

Authors:  Sibtain Ahmed; Aahan Arif; Saadia Abbas; Muhammad Osama Khan; Salman Kirmani; Aysha Habib Khan
Journal:  Ann Med Surg (Lond)       Date:  2021-01-19

4.  Hajdu-Cheney Syndrome: A Novel NOTCH2 Mutation in a Spanish Child in Treatment with Vibrotherapy: A Case Report.

Authors:  Jonathan Cortés-Martín; Lourdes Díaz-Rodríguez; Beatriz Piqueras-Sola; Juan Carlos Sánchez-García; Antonio Liñán González; Raquel Rodríguez-Blanque
Journal:  J Clin Med       Date:  2022-09-02       Impact factor: 4.964

Review 5.  Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - new data and literature review.

Authors:  James F H Pittaway; Christopher Harrison; Yumie Rhee; Muriel Holder-Espinasse; Alan E Fryer; Tim Cundy; William M Drake; Melita D Irving
Journal:  Orphanet J Rare Dis       Date:  2018-04-04       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.